|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1001564860 |
003 |
OCoLC |
005 |
20231120010214.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
170823s2017 mau ob 000 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d IDEBK
|d EBLCP
|d YDX
|d N$T
|d OCLCF
|d UPM
|d BNG
|d OCL
|d D6H
|d UWW
|d DKU
|d UAB
|d AU@
|d OCLCO
|d OCLCA
|d NLW
|d ESU
|d UKAHL
|d OCLCQ
|d S2H
|d OCLCQ
|d OCLCO
|d UX1
|d VT2
|d OCLCQ
|d OCLCO
|d AAA
|d OCLCO
|d OCLCQ
|d OCLCO
|
066 |
|
|
|c (S
|
019 |
|
|
|a 1001571858
|a 1001755771
|a 1235834116
|
020 |
|
|
|a 9780128112335
|q (electronic bk.)
|
020 |
|
|
|a 0128112336
|q (electronic bk.)
|
020 |
|
|
|z 9780128112328
|q (print)
|
020 |
|
|
|z 0128112328
|q (print)
|
035 |
|
|
|a (OCoLC)1001564860
|z (OCoLC)1001571858
|z (OCoLC)1001755771
|z (OCoLC)1235834116
|
050 |
|
4 |
|a RM666.C266
|
060 |
|
4 |
|a QV 77.7
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.7/827
|2 23
|
245 |
0 |
0 |
|a Cannabinoid pharmacology /
|c edited by David Kendall and Stephen P.H. Alexander.
|
264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c 2017.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in pharmacology ;
|v volume 80
|
588 |
0 |
|
|a Online resource; title from title details screen (ScienceDirect, viewed August 23, 2017).
|
505 |
0 |
0 |
|t Preface /
|r David Kendall, Stephen P.H. Alexander --
|t Endocannabinoid analytical methodologies : techniques that drive discoveries that drive techniques /
|r Fabiana Piscitelli, Heather B. Bradshaw --
|t Endocannabinoid turnover /
|r Christopher J. Fowler, Patrick Doherty, Stephen P.H. Alexander --
|t Cannabis pharmacology : the usual suspects and a few promising leads /
|r Ethan B. Russo, Jahan Marcu --
|t Spicing up pharmacology : a review of synthetic cannabinoids from structure to adverse events /
|r Colin Davidson, Jolanta Opacka-Juffry, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Eduardo Molina-Holgado, Francisco Molina-Holgado --
|t CB₁ and CB₂ receptor pharmacology /
|r Allyn C. Howlett, Mary E. Abood --
|t Functional selectivity at cannabinoid receptors /
|r Richard Priestley, Michelle Glass, David Kendall --
|t Cannabinoid receptor-related orphan G protein-coupled receptors /
|r Andrew Irving, Ghayth Abdulrazzaq, Sue L.F. Chan, June Penman, Jenni Harvey, Stephen P.H. Alexander --
|t Actions and regulation of ionotropic cannabinoid receptors /
|r Luciano De Petrocellis, Massimo Nabissi, Giorgio Santoni, Alessia Ligresti --
|t Role of nuclear hormone receptors in cannabinoid function /
|r Marco Pistis, Saoirse E. O'Sullivan --
|t Cannabinoids in the cardiovascular system /
|r Wing S.V. Ho, Melanie E.M. Kelly --
|t Is the cannabinoid CB₂ receptor a major regulator of the neuroinflammatory axis of the neurovascular unit in humans? /
|r Dan T. Kho, Michelle Glass, Euan S. Graham --
|t Cannabinoids as anticancer drugs /
|r Robert Ramer, Burkhard Hinz --
|t Cannabinoids and pain : sites and mechanisms of action /
|r Katarzyna Starowicz, David P. Finn.
|
504 |
|
|
|a Includes bibliographical references.
|
520 |
|
|
|a Cannabinoid Pharmacology, Volume 80 is a new volume in the Advances in Pharmacology that presents reviews of recent breakthroughs. This volume aims to present current knowledge of the endogenous cannabinoid system, and looks at molecular, cellular, tissue and organismal effects of endogenous and exogenous cannabinoids. Topics of note in this new volume include Endocannabinoids and their congeners, Endocannabinoid turnover, Plant cannabinoids, Synthetic cannabinoids and 'legal highs', CB1 and CB2 cannabinoid receptors, Novel signaling modalities, Novel cannabinoid receptors, and Ion channel regulation by cannabinoids. There is a broad coverage of the essential elements associated with the cannabinoid system. The Editors have sought to include authors who represent authoritative voices on these themes, but have not previously worked together to allow a fresh approach to the individual aspects covered. Presents reviews of recent breakthroughs in the cannabinoid system. Features chapters from the best authors in the field. Provides an essential resource for scientists, advanced undergraduate students through to established faculty members.--Provided by publisher.
|
650 |
|
0 |
|a Cannabinoids.
|
650 |
|
0 |
|a Cannabinoids
|x Physiological effect.
|
650 |
|
2 |
|a Cannabinoids
|x pharmacology
|0 (DNLM)D002186Q000494
|
650 |
|
2 |
|a Cannabinoids
|0 (DNLM)D002186
|
650 |
|
6 |
|a Cannabino�ides.
|0 (CaQQLa)201-0078335
|
650 |
|
6 |
|a Cannabino�ides
|0 (CaQQLa)201-0078335
|x Effets physiologiques.
|0 (CaQQLa)201-0374337
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Cannabinoids
|x Physiological effect
|2 fast
|0 (OCoLC)fst00845735
|
650 |
|
7 |
|a Cannabinoids
|2 fast
|0 (OCoLC)fst00845733
|
700 |
1 |
|
|a Kendall, David,
|e editor.
|
700 |
1 |
|
|a Alexander, S. P. H.
|q (Stephen P. H.),
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Cannabinoid pharmacology
|z 9780128112328
|z 0128112328
|w (OCoLC)974698743
|
830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v 80.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/10543589/80
|z Texto completo
|
880 |
8 |
|
|6 505-00/(S
|a 5.4. β-Elemene
|
880 |
8 |
|
|6 505-00/(S
|a 2.7. Tetrahydrocannabinolic Acid2.8. Cannabidivarin; 2.9. Cannabidiolic Acid; 2.10. Cannabigerol Monomethyl Ether; 3. Cannabis Terpenoids; 4. Cannabis Monoterpenoids (Fig. 3); 4.1. β-Myrcene; 4.2. d-Limonene; 4.3. β-Ocimene; 4.4. γ-Terpinene; 4.5. α-Terpinene; 4.6. α-Terpineol; 4.7. α-Pinene; 4.8. β-Pinene; 4.9. Linalool; 4.10. Camphene; 4.11. Terpinolene; 4.12. α-Phellandrene; 4.13. γ-Cadinene; 4.14. Δ3-Carene; 4.15. ρ-Cymene; 4.16. Fenchol; 4.17. 1,8-Cineole (Eucalyptol); 5. Cannabis Sesquiterpenoids (Fig. 4); 5.1. β-Caryophyllene; 5.2. Caryophyllene Oxide; 5.3. Humulene (α-Caryophyllene)
|